Loading…
Loading…
AI-Powered Customer Engagement Segment Contributed $6.31 Million in Quarterly Revenue as Stockholders' Equity Climbed to $49.1 Million from $9.9 Million PLEASANTON, Calif., Aug. 13, 2026 /PRNewswire/ -- Healthcare Triangle, Inc. (Nasdaq: HCTI) ("HCTI" or the "Company"), a technology company delivering AI-powered customer engagement and digital transformation services, is today reporting financial results for the second quarter ended June 30, 2026, which includes second quarter revenue of $9.19 million, up 158% year over year, with gross profit up 322% to $2.07 million.
Client Has Already Matched Its Full-Year 2025 Revenue by June 2026, with Annual Turnover Projected to Reach €2 Million PLEASANTON, Calif., Aug. 6, 2026 /PRNewswire/ -- Healthcare Triangle, Inc. (Nasdaq: HCTI) ("HCTI" or the "Company"), a leader in digital transformation, artificial intelligence, and cloud-infrastructure solutions for healthcare and life sciences organizations, today reported that its subsidiary, Teyame Holdings Inc. ("Teyame"), has released a progress report highlighting exceptional growth achieved on behalf of a key client — one of Spain's leading health insurance companies.
Transaction introduces 27 granted international patents, 61 pending applications , and a commercial pipeline targeting over US $50 million in cumulative revenue over three years. PLEASANTON, Calif.
Common shares outstanding increase to 14,644,322 following the closing of two previously approved transactions, providing added cushion under Nasdaq's newly effective Market Value of Listed Securities (MVLS) requirement PLEASANTON, Calif., July 29, 2026 /PRNewswire/ -- Healthcare Triangle, Inc. (Nasdaq: HCTI) ("HCTI" or the "Company"), a leader in digital transformation, artificial intelligence, and cloud-infrastructure solutions for healthcare and life sciences organizations, today reported that, on July 24, 2026, it completed the issuance of an aggregate of 12,546,540 shares of common stock in connection with two previously shareholder-approved transactions: the closing of its acquisition involving Teyame AI LLC and related parties (the "Teyame Transaction"), and a Share Exchange Agreement with SecureKloud Technologies Ltd.
Names Veteran Health Tech & AI Services Leader Sumit Ganguli as Chairman & CEO to Fuel Multi-Year Recurring Revenue Growth Across a Multi-Billion-Dollar Healthcare AI Market PLEASANTON, Calif., July 27, 2026 /PRNewswire/ -- Healthcare Triangle, Inc. (NASDAQ: HCTI), a healthcare and life sciences technology company enabling digital transformation through cloud, data, artificial intelligence, and security solutions, today announced that proven industry executive Sumit Ganguli has been appointed Chairman and Chief Executive Officer of Purpose Health, Inc., HCTI's wholly owned, AI-led healthcare technology services subsidiary.
JERSEY CITY, N.J., June 12, 2026 /PRNewswire/ -- WallachBeth Capital LLC, a leading provider of capital markets and institutional execution services, announces the closing of Healthcare Triangle, Inc. (Nasdaq: HCTI) private placement of 15% original issue discount senior convertible promissory notes in the aggregate principal amount of $4.235 Million for aggregate gross proceeds of approximately $3.6 million, before deducting placement agent fees and other offering expenses.
PLEASANTON, Calif., June 12, 2026 /PRNewswire/ -- Healthcare Triangle, Inc. (Nasdaq: HCTI) ("HCTI" or the "Company"), a leader in digital transformation solutions for healthcare and life sciences, today announces the closing of a private placement of its 15% original issue discount senior convertible promissory notes in the aggregate principal amount of $4.235 million for aggregate gross proceeds of approximately $3.6 million, before deducting placement agent fees and other related offering expenses.
Recent Acquisitions powers the Revenue Growth and Gross Profit PLEASANTON, Calif., May 14, 2026 /PRNewswire/ -- Healthcare Triangle, Inc. (Nasdaq: HCTI) ("HCTI" or the "Company"), a leader in digital transformation solutions for healthcare and life sciences, today reported financial results for the first quarter ended March 31, 2026.